Healthcare Realty Trust Inc
NYSE:HR

Watchlist Manager
Healthcare Realty Trust Inc Logo
Healthcare Realty Trust Inc
NYSE:HR
Watchlist
Price: 17.96 USD 2.69% Market Closed
Market Cap: $6.3B

Healthcare Realty Trust Inc
Investor Relations

Healthcare Realty Trust Inc. is a real estate investment trust (REIT) that specializes in owning, managing, and developing properties primarily associated with outpatient healthcare services. Picture this company as a crucial puzzle piece in the ever-evolving healthcare landscape; it provides the physical space where crucial medical services are delivered, from comprehensive outpatient clinics to specialized centers for diagnostics and treatment. Born from a recognition of the rising demand for healthcare facilities, the company has meticulously assembled a portfolio that supports the healthcare sector's shifting focus toward outpatient care, where patients can receive specialized services without the need for an overnight hospital stay.

In terms of its business model, Healthcare Realty Trust earns revenue primarily through leasing its properties to a variety of healthcare providers, from major hospital systems to smaller independent medical practices. By working closely with these tenants, the company ensures that facilities are tailored to meet healthcare providers' specific needs. This tenant-focused strategy not only helps the company maintain high occupancy rates but also encourages long-term leasing agreements. Consequently, Healthcare Realty Trust's steady stream of rental income becomes a reliable source of cash flow, which is further supported by its adept property management and strategic acquisitions, reinforcing its reputation as a leading provider of healthcare real estate solutions.

Show more
Loading
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
Last Earnings Call
Fiscal Period
Q4 2025
Call Date
Feb 13, 2026
AI Summary
Q4 2025

FFO Beat: Normalized FFO for 2025 was $1.61 per share, beating the midpoint of original guidance by $0.03, with Q4 FFO at $0.40 per share.

NOI Outperformance: Same-store NOI growth was 4.8% for the year, exceeding guidance by 140 basis points; Q4 same-store cash NOI growth reached 5.5%.

G&A Savings: Achieved $10 million in run rate G&A savings ahead of plan, with total G&A expense at $45 million.

Asset Dispositions: Completed $1.2 billion in asset sales at a 6.7% cap rate, exiting 14 noncore markets, and improving geographic footprint.

Leverage Down: Reduced net debt to EBITDA from 6.4x to 5.4x, improving financial flexibility and extending debt maturities.

Dividend Reset: Rightsized the dividend, now offering nearly a 6% yield and described as well-covered and able to grow under the right conditions.

2026 Guidance: Midpoint FFO guidance for 2026 is $1.61 per share, with embedded 5% core earnings growth offset by dilution from asset sales.

Redevelopment Focus: Redevelopment projects prioritized, showing strong lease-up momentum and expected to be key drivers of future earnings.

Key Financials
Normalized FFO per Share
$1.61
Q4 Normalized FFO per Share
$0.40
Same-Store NOI Growth
4.8%
Q4 Same-Store Cash NOI Growth
5.5%
Funds Available for Distribution (FAD) per Share
$1.26
Q4 FAD per Share
$0.32
Dividend Payout Ratio
75%
Total G&A Expense
$45 million
Cash Leasing Spreads
3.7%
Asset Dispositions
$1.2 billion
Cap Rate on Dispositions
6.7%
Net Debt to EBITDA
5.4x
Tenant Retention
82% (full year); nearly 83% (Q4)
Leasing Activity
5.8 million square feet in 2025; 1.5 million square feet in Q4
Annual Escalators (New Leases)
3.1% (all leasing activity); 2.9% (portfolio average)
Weighted Average Lease Term
Nearly 6 years
Same-Store Occupancy Gain
Over 100 basis points (full year); over 20 basis points (Q4)
Dividend Yield
Nearly 6%
Share Repurchases
$50 million in January (2.9 million shares); $450 million authorization remaining
Other Earnings Calls

Management

Ms. Constance B. Moore
Interim President, CEO & Director
No Bio Available
Mr. Robert E. Hull
Executive VP & COO
No Bio Available
Ms. Julie F. Wilson
Executive VP & Chief Administrative Officer
No Bio Available
Mr. John M. Bryant Jr.
Executive VP & General Counsel
No Bio Available
Mr. Austen Helfrich
Interim Chief Financial Officer
No Bio Available
Ms. Amanda L. Callaway
Senior VP & Chief Accounting Officer
No Bio Available
Mr. Andy Baxter
VP & CTO
No Bio Available
Mr. Ronald M. Hubbard
Vice President of Investor Relations
No Bio Available
Ms. Bethany A. Mancini
Associate Vice President of Corporate Communications
No Bio Available
Ms. Revell M. Michael
Vice President of Marketing
No Bio Available

Contacts

Address
TENNESSEE
Nashville
3310 W End Ave
Contacts